Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof
The invention relates to an exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor as well as a composition and application thereof, in particular to a compound as shown in a formula (I), or pharmaceutically acceptable salt, stereoisomer, hydrate, deuterated substance or prodrug thereof...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG YITIAN ZHANG SULIN HUANG LIN WU XIAOWEI YANG RUIRUI YANG PEILING WANG QIANG ZHENG MINGYUE MENG HAIFANG |
| description | The invention relates to an exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor as well as a composition and application thereof, in particular to a compound as shown in a formula (I), or pharmaceutically acceptable salt, stereoisomer, hydrate, deuterated substance or prodrug thereof, and a pharmaceutical composition containing the compound and the pharmaceutical composition and application thereof. The compound can be used as an ENPP1 inhibitor, and is used for treating and/or preventing diseases related to ENPP1 dysfunction. # imgabs0 #
本发明涉及一类外核苷酸焦磷酸酶/磷酸二酯酶1(ENPP1)抑制剂及其组合物和用途，具体地，本发明涉及式(I)所示化合物，或者其药学上可接受的盐、立体异构体、水合物、氘代物或者前药以及含有它们的药物组合物和其用途。所述化合物可以作为ENPP1抑制剂，用于治疗和/或预防与ENPP1功能障碍相关的疾病。#imgabs0# |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118684631A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118684631A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118684631A3</originalsourceid><addsrcrecordid>eNqNijEKwkAQANNYiPqHTaeFyBEJaSVErEIK-3Ame9xCvD1uN6C_V4gPsJphmHXmmheHeZiQlUaE-E4cPUv0Vq3gaXEeCUUxfQsY2Ddt15kDUPD0IOUkYMMIAz8jCylxWMIsKKAeE7LbZitnJ8Hdj5ssvzb3-nbEyD1KtAMG1L5ujanK6lwW5lL883wAvWU_7w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof</title><source>esp@cenet</source><creator>WANG YITIAN ; ZHANG SULIN ; HUANG LIN ; WU XIAOWEI ; YANG RUIRUI ; YANG PEILING ; WANG QIANG ; ZHENG MINGYUE ; MENG HAIFANG</creator><creatorcontrib>WANG YITIAN ; ZHANG SULIN ; HUANG LIN ; WU XIAOWEI ; YANG RUIRUI ; YANG PEILING ; WANG QIANG ; ZHENG MINGYUE ; MENG HAIFANG</creatorcontrib><description>The invention relates to an exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor as well as a composition and application thereof, in particular to a compound as shown in a formula (I), or pharmaceutically acceptable salt, stereoisomer, hydrate, deuterated substance or prodrug thereof, and a pharmaceutical composition containing the compound and the pharmaceutical composition and application thereof. The compound can be used as an ENPP1 inhibitor, and is used for treating and/or preventing diseases related to ENPP1 dysfunction. # imgabs0 #
本发明涉及一类外核苷酸焦磷酸酶/磷酸二酯酶1(ENPP1)抑制剂及其组合物和用途，具体地，本发明涉及式(I)所示化合物，或者其药学上可接受的盐、立体异构体、水合物、氘代物或者前药以及含有它们的药物组合物和其用途。所述化合物可以作为ENPP1抑制剂，用于治疗和/或预防与ENPP1功能障碍相关的疾病。#imgabs0#</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240924&DB=EPODOC&CC=CN&NR=118684631A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240924&DB=EPODOC&CC=CN&NR=118684631A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG YITIAN</creatorcontrib><creatorcontrib>ZHANG SULIN</creatorcontrib><creatorcontrib>HUANG LIN</creatorcontrib><creatorcontrib>WU XIAOWEI</creatorcontrib><creatorcontrib>YANG RUIRUI</creatorcontrib><creatorcontrib>YANG PEILING</creatorcontrib><creatorcontrib>WANG QIANG</creatorcontrib><creatorcontrib>ZHENG MINGYUE</creatorcontrib><creatorcontrib>MENG HAIFANG</creatorcontrib><title>Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof</title><description>The invention relates to an exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor as well as a composition and application thereof, in particular to a compound as shown in a formula (I), or pharmaceutically acceptable salt, stereoisomer, hydrate, deuterated substance or prodrug thereof, and a pharmaceutical composition containing the compound and the pharmaceutical composition and application thereof. The compound can be used as an ENPP1 inhibitor, and is used for treating and/or preventing diseases related to ENPP1 dysfunction. # imgabs0 #
本发明涉及一类外核苷酸焦磷酸酶/磷酸二酯酶1(ENPP1)抑制剂及其组合物和用途，具体地，本发明涉及式(I)所示化合物，或者其药学上可接受的盐、立体异构体、水合物、氘代物或者前药以及含有它们的药物组合物和其用途。所述化合物可以作为ENPP1抑制剂，用于治疗和/或预防与ENPP1功能障碍相关的疾病。#imgabs0#</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEKwkAQANNYiPqHTaeFyBEJaSVErEIK-3Ame9xCvD1uN6C_V4gPsJphmHXmmheHeZiQlUaE-E4cPUv0Vq3gaXEeCUUxfQsY2Ddt15kDUPD0IOUkYMMIAz8jCylxWMIsKKAeE7LbZitnJ8Hdj5ssvzb3-nbEyD1KtAMG1L5ujanK6lwW5lL883wAvWU_7w</recordid><startdate>20240924</startdate><enddate>20240924</enddate><creator>WANG YITIAN</creator><creator>ZHANG SULIN</creator><creator>HUANG LIN</creator><creator>WU XIAOWEI</creator><creator>YANG RUIRUI</creator><creator>YANG PEILING</creator><creator>WANG QIANG</creator><creator>ZHENG MINGYUE</creator><creator>MENG HAIFANG</creator><scope>EVB</scope></search><sort><creationdate>20240924</creationdate><title>Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof</title><author>WANG YITIAN ; ZHANG SULIN ; HUANG LIN ; WU XIAOWEI ; YANG RUIRUI ; YANG PEILING ; WANG QIANG ; ZHENG MINGYUE ; MENG HAIFANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118684631A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG YITIAN</creatorcontrib><creatorcontrib>ZHANG SULIN</creatorcontrib><creatorcontrib>HUANG LIN</creatorcontrib><creatorcontrib>WU XIAOWEI</creatorcontrib><creatorcontrib>YANG RUIRUI</creatorcontrib><creatorcontrib>YANG PEILING</creatorcontrib><creatorcontrib>WANG QIANG</creatorcontrib><creatorcontrib>ZHENG MINGYUE</creatorcontrib><creatorcontrib>MENG HAIFANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG YITIAN</au><au>ZHANG SULIN</au><au>HUANG LIN</au><au>WU XIAOWEI</au><au>YANG RUIRUI</au><au>YANG PEILING</au><au>WANG QIANG</au><au>ZHENG MINGYUE</au><au>MENG HAIFANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof</title><date>2024-09-24</date><risdate>2024</risdate><abstract>The invention relates to an exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor as well as a composition and application thereof, in particular to a compound as shown in a formula (I), or pharmaceutically acceptable salt, stereoisomer, hydrate, deuterated substance or prodrug thereof, and a pharmaceutical composition containing the compound and the pharmaceutical composition and application thereof. The compound can be used as an ENPP1 inhibitor, and is used for treating and/or preventing diseases related to ENPP1 dysfunction. # imgabs0 #
本发明涉及一类外核苷酸焦磷酸酶/磷酸二酯酶1(ENPP1)抑制剂及其组合物和用途，具体地，本发明涉及式(I)所示化合物，或者其药学上可接受的盐、立体异构体、水合物、氘代物或者前药以及含有它们的药物组合物和其用途。所述化合物可以作为ENPP1抑制剂，用于治疗和/或预防与ENPP1功能障碍相关的疾病。#imgabs0#</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN118684631A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Exonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors and compositions and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T11%3A26%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20YITIAN&rft.date=2024-09-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118684631A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |